Document Detail


Diurnal variation in Cotard's syndrome (copresent with Capgras delusion) following traumatic brain injury.
MedLine Citation:
PMID:  10954402     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: The aim of this paper is to document regular nocturnal intensification of delusional nihilistic and persecutory ideas (Cotard delusion) linked with extreme depersonalisation and hypervivid dreaming. CLINICAL PICTURE: A 17-year-old man presented with Cotard and Capgras delusions after sustaining multiple cognitive impairments secondary to traumatic brain injury. Treatment and outcome: Delusional ideation fully resolved within 14 days of commencement of olanzapine 5 mg daily. CONCLUSION: This patient's experience of perceptual abnormalities and impairments in meta-abilities related to self-monitoring and critical inferencing lends support to multicomponent sensory processing accounts of brain injury related, content-specific delusional syndromes.
Authors:
P V Butler
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  The Australian and New Zealand journal of psychiatry     Volume:  34     ISSN:  0004-8674     ISO Abbreviation:  Aust N Z J Psychiatry     Publication Date:  2000 Aug 
Date Detail:
Created Date:  2000-12-22     Completed Date:  2000-12-22     Revised Date:  2009-11-11    
Medline Journal Info:
Nlm Unique ID:  0111052     Medline TA:  Aust N Z J Psychiatry     Country:  AUSTRALIA    
Other Details:
Languages:  eng     Pagination:  684-7     Citation Subset:  IM    
Affiliation:
Royal Rehabilitation Centre, Ryde, New South Wales, Australia. butlerp@doh.health.nsw.gov.au
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Antipsychotic Agents / administration & dosage,  therapeutic use
Benzodiazepines
Brain Injuries / complications*
Capgras Syndrome / diagnosis,  drug therapy,  etiology*
Circadian Rhythm / physiology*
Delusions / diagnosis,  drug therapy,  etiology*,  psychology*
Humans
Male
Perceptual Disorders / etiology
Pirenzepine / administration & dosage,  analogs & derivatives,  therapeutic use
Syndrome
Chemical
Reg. No./Substance:
0/Antipsychotic Agents; 12794-10-4/Benzodiazepines; 132539-06-1/olanzapine; 28797-61-7/Pirenzepine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Trends in Maori mental health in Otago.
Next Document:  Cognitive-behavioural assessment and treatment of maladaptive help-seeking behaviour in a patient wi...